Macrophage MHC and T-Cell receptors essential for rejection of allografted skin and lymphoma

Transplantation

Volumn 96, Issue 3, 2013, Pages 251-257

  Tashiro Yamaji, Junko ^a   Maeda, Shogo ^a   Ikawa, Masahito ^b   Okabe, Masaru ^b   Kubota, Takahiro ^a   Yoshida, Ryotaro ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Allograft; Knockout; MHC; Receptor; Rodent

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR; MAJOR HISTOCOMPATIBILITY COMPLEX RECEPTOR 1; MAJOR HISTOCOMPATIBILITY COMPLEX RECEPTOR 2; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL COUNT; CELLULAR IMMUNITY; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE FUNCTION; GENE LOSS; GRAFT REJECTION; KNOCKOUT MOUSE; LYMPHOID TISSUE; LYMPHOMA; LYMPHOMA CELL LINE; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MMR1 GENE; MMR2 GENE; MONOCYTE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN ALLOGRAFT; TRANSGENIC MOUSE;

ANIMALS; GRAFT REJECTION; H-2 ANTIGENS; HEK293 CELLS; HISTOCOMPATIBILITY ANTIGEN H-2D; HUMANS; HYPERSENSITIVITY, DELAYED; LYMPHOMA; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IMMUNOLOGIC; SKIN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 84881610067     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182985527     Document Type: Article

References (38)

1. Ichikawa T, Nakayama E, Uenaka A, et al. Effector cells in allelic H-2 class I-incompatible skin graft rejection. J Exp Med 1987; 166: 982.
2. Strom TB, Tilney NL, Carpenter CB, et al. Identity and cytotoxic capacity of cells infiltrating renal allografts. N Engl JMed 1975; 292: 1257.
3. Ascher NL, Ferguson RM, Hoffman R, et al. Partial characterization of cytotoxic cells infiltrating sponge matrix allografts. Transplantation 1979; 27: 254.
4. Zijlstra M, Auchincloss H Jr, Loring JM, et al. Skin graft rejection by A2-microglobulin-deficient mice. J Exp Med 1992; 175: 885.
5. Dalloul AH, Chmouzis E, Ngo K, et al. Adoptively transferred CD4+ lymphocytes from CD8-/-mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts. J Immunol 1996; 156: 4114.
6. KriegerNR, Yin DP, Fathman CG. CD4+ but not CD8+ cells are essential for allorejection. J ExpMed 1996; 184: 2013.
7. Noguchi Y, Chen YT, Old LJ. A mouse mutant p53 product recognized by CD4+ and CD8+ T cells. Proc Natl Acad Sci USA 1994; 91: 3171.
8. Woglom WH. Immunity to transplantable tumors. Cancer Res 1929; 4: 129.
9. YoshidaR, Park SW, YasuiH, et al. Tryptophan degradation in transplanted tumor cells undergoing rejection. J Immunol 1988; 141: 2819.
10. Gorer PA. The detection of antigenic differences in mouse erythrocytes by the employment of immune sera. Br J Exp Pathol 1936; 17: 42.
11. Gorer PA. The genetic and antigenic basis of tumor transplantation. J Pathol Bacteriol 1937; 44: 691.
12. Gorer PA. Further studies on antigenic differences in mouse erythrocytes. Br J Exp Pathol 1937; 18: 31.
13. Snell GD, Stimpfling JH. Genetics of tissue transplantation. In: Green EL, ed. Biology of the Laboratory Mouse. 2nd ed. New York, NY: McGraw-Hill; 1966; 457.
14. Gorer PA, Lyman S, Snell GD. Studies on the genetic and antigenic basis of tumour transplantation. Linkage between a histocompatibility gene and "fused" in mice. Proc R S Lond Ser B Biol Sci 1948; 135: 499.
15. Yoshida R, Takikawa O, Oku T, et al. Mononuclear phagocytes: a major population of effector cells responsible for rejection of allografted tumor cells in mice. Proc Natl Acad Sci USA 1991; 88: 1526.
16. Yamamoto N, Einaga-Naito K, Kuriyama M, et al. Cellular basis of skin allograft rejection in mice: specific lysis of allogeneic skin components by non-T cells. Transplantation 1998; 65: 818.
17. Ushio Y, Yamamoto N, Sanchez-Bueno A, et al. Failure to reject an allografted tumor after elimination of macrophages in mice. Microbiol Immunol 1996; 40: 489.
18. Yoshida R, Matsuura A, Einaga K, et al. Two distinct populations of primary cytotoxic cells infiltrating into allografted tumor rejection sites: infiltration of macrophages cytotoxic against allografted tumor precedes that of multiple sets of cytotoxic T lymphocytes with distinct specificity to alloantigens. Microbiol Immunol 1997; 41: 149.
19. Yoshida R, Sanchez-Bueno A, Yamamoto N, et al. Ca2+-dependent, Fasand perforin-independent apoptotic death of allografted tumor cells by a type of activated macrophage. J Immunol 1997; 159: 15.
20. Yoshida R, Yoneda Y, KuriyamaM, et al. IFN-F-and cell-to-cell contactdependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment. J Immunol 1999; 163: 148.
21. Yoshida R, Oku T, Takikawa O, et al. Leukocyte integrin-dependent and antibody-independent cytotoxicity of macrophage against allografts. Microbiol Immunol 2000; 44: 57.
22. Lee K, Takenaka H, Yoneda Y, et al. Differential susceptibility of cells expressing allogeneicMHC or viral antigen to killing by antigen-specific CTL. Microbiol Immunol 2004; 48: 15.
23. Nomi H, Tashiro-Yamaji J, Miura-Takeda S, et al. Infiltration of H-2d-specific cytotoxic macrophage with unique morphology into rejection site of allograftedMeth A (H-2d) tumor cells in C57BL/6 (H-2b) mice. Microbiol Immunol 2007; 51: 297.
24. Yoneda Y, Tashiro-Yamaji J, Kubota T, et al. Two types of allograftinduced cytotoxic macrophage, one against allografts and the other against syngeneic or allogeneic tumor cells. Microbiol Immunol 2008; 52: 349.
25. Tashiro-Yamaji J, Einaga-Naito K, Kubota T, et al. A novel receptor on allograft (H-2d)-induced macrophage (H-2b) toward an allogeneic major histocompatibility complex class I molecule, H-2Dd, in mice. Microbiol Immunol 2006; 50: 105.
26. Tashiro-Yamaji J, Kubota T, Yoshida R. Macrophage MHC receptor 2: a novel receptor on allograft (H-2DdKd)-induced macrophage (H-2DbKb) recognizing anMHC class I molecule,H-2Kd, inmice. Gene 2006; 384: 1.
27. Tashiro-Yamaji J, Shimizu T, Hayashi M, et al. Specific binding of HLAB44 to human macrophage MHC receptor 1 on monocytes. Gene 2012; 501: 127.
28. Shimizu T, Tashiro-Yamaji J, Hayashi M, et al. HLA-B62 as a possible ligand for the human homologue of mouse macrophage MHC receptor 2 (MMR2) on monocytes. Gene 2010; 454: 31.
29. Inoue Y, Tashiro-Yamaji J, Hayashi M, et al. Transgene numberdependent, gene expression rate-independent rejection of Dd-, Kd-, or DdKd-transgenedmouse skin or tumor cells fromC57BL/6 (DbKb) mice. Microbiol Immunol 2011; 55: 446.
30. He C, Heeger PS. CD8 T cells can reject major histocompatibility complex class I-deficient skin allografts. Am J Transplant 2004; 4: 698.
31. Loveland BE, Hogarth PM, Ceredic R, et al. Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection. J Exp Med 1981; 153: 1044.
32. Liew FY, Simpson E. Delayed-type hypersensitivity response to H-Y: characterization andmapping of Ir genes. Immunogenetics 1980; 11: 255.
33. Kurimoto I, Streilein JW. Studies of contact hypersensitivity induction in mice with optimal sensitizing doses of hapten. J Invest Dermatol 1993; 101: 132.
34. IkawaM,Wada I,Kominami K, et al. The putative chaperone calmegin is required for sperm fertility. Nature 1997; 387: 607.
35. Gordon JW, Scangos GA, Plotkin DJ, et al. Genetic transformation of mouse embryos by microinjection of purified DNA. Proc Natl Acad Sci USA 1980; 77: 7380.
36. Billingham RE, Medawar PB. Technique of free skin grafting in mammals. J Exp Biol 1951; 28: 385.
37. Miyoshi-Higashino M, Hirano M, Ogita-Nakanishi H, et al. IL-4-dependent induction of IgE+ basophils in peripheral blood and IgE+ B cells in spleen as respective indicators of allergen sensitization and a precursor of cells secreting allergen-specific IgE antibody. Microbiol Immunol 2009; 53: 30.
38. Lyons AB, Parish CR. Determination of lymphocyte division by flow cytometry. J Immunol Methods 1994; 171: 131.